Physician profile
Stephen M Sims
NPI 1083623136
$19,983.40
in general payments reported to CMS, 2019-2025
48 companies · $2,152 in 2025
The $2,152 reported for 2025 was more than what 80% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,676 · 2020: $1,030 · 2021: $4,748 · 2022: $3,740 · 2023: $2,553 · 2024: $4,084 · 2025: $2,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,551 · Consulting Fee: $3,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,551.33 |
| Consulting Fee | $3,237.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,477.37 | 2019-2025 | Proclaim, Eterna, Octrode |
| Mml US, INC. | $1,851.06 | 2022-2024 | Reactiv8 |
| Abbvie INC. | $1,282.94 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Boston Scientific Corporation | $1,039.24 | 2020-2022 | |
| Relievant Medsystems, INC. | $542.56 | 2021-2023 | Intracept |
| Pacira Therapeutics, INC. | $493.63 | 2019-2021 | |
| Medtronic, INC. | $489.71 | 2021-2025 | V-Loc 180, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Vertos Medical, INC. | $453.42 | 2022-2023 | Mild Device Kit |
| Si-Bone, INC. | $395.44 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $375.57 | 2019-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $239.92 | 2019-2025 | Belbuca, Xtampza |
| Mdd US Operations, LLC | $236.40 | 2019-2020 | |
| Spinal Simplicity, LLC | $176.74 | 2021 | |
| Amgen INC. | $146.86 | 2019-2022 | |
| Biotronik INC. | $128.07 | 2022 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $125.08 | 2025 | Nalu Neurostimulation System |
| Vertiflex, INC. | $119.62 | 2019 | |
| Pfizer INC. | $113.78 | 2019-2025 | |
| Surgentec | $110.00 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $96.62 | 2023-2025 | Iovera, Zilretta, Exparel |
| Medtronic USA, INC. | $85.42 | 2019-2020 | |
| Globus Medical, INC. | $80.45 | 2025 | Senza, Vyrsa V1 |
| Teva Pharmaceuticals USA, INC. | $74.45 | 2019-2020 | |
| Biotronik Nro, INC. | $65.50 | 2024-2025 | Prospera |
| Merz North America, INC. | $55.41 | 2019 | |
| Allergan, INC. | $51.88 | 2020-2021 | |
| Bioventus LLC | $51.76 | 2019-2024 | Durolane, Durolane |
| Biodelivery Sciences International, INC. | $50.91 | 2019-2021 | |
| Stryker Corporation | $49.71 | 2024-2025 | Optablate, Omnicurve, Mild Device Kit |
| Almatica Pharma LLC | $49.26 | 2021 | |
| Grt US Holding, INC. | $42.21 | 2021 | |
| Idorsia Pharmaceuticals US INC | $38.53 | 2023 | Quviviq |
| Valinor Pharma, LLC | $37.31 | 2025 | Movantik |
| Tersera Therapeutics LLC | $36.46 | 2025 | Prialt |
| Saluda Medical Americas, INC. | $35.80 | 2023-2025 | Evoke, Evoke Scs |
| Lundbeck LLC | $34.09 | 2021-2022 | |
| Averitas Pharma INC. | $31.57 | 2023-2025 | Qutenza |
| Merz Pharmaceuticals, LLC | $31.21 | 2022 | |
| Scilex Pharmaceuticals INC. | $26.62 | 2020-2022 | |
| Spr Therapeutics, INC | $22.91 | 2025 | Sprint Pns System |
| Fidia Pharma USA INC. | $22.42 | 2024 | Hymovis |
| Azurity Pharmaceuticals, INC. | $21.41 | 2024 | Horizant |
| Vertex Pharmaceuticals Incorporated | $20.14 | 2025 | |
| Nevro Corp. | $18.54 | 2019 | |
| Masimo Corporation | $16.76 | 2024 | Patient Safetynet System |
| Cook Medical LLC | $14.62 | 2024 | Zilver Ptx |
| Assertio Therapeutics, INC. | $12.16 | 2019 | |
| Depuy Synthes Sales INC. | $11.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Sims listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.